Tag Archives: RMTI

candlestick chart

Rethink Technology business briefs for March 2, 2017

Finally, Reliable Testing Tells the True Ryzen Story

Source: AnandTech

First, let me try to clear up some of the confusion I’ve seen in comments about what I have or have not said about Advanced Micro Devices’ (NASDAQ:AMD) Ryzen. I’ve seen claims that I said that Ryzen wouldn’t be “competitive.”

Actually, since the reveal of Ryzen last August, I’ve been fairly circumspect about not making sweeping generalizations about Zen, now Ryzen, performance. Then I wrote:

Let me first say that I do agree that Summit Ridge is a significant technical accomplishment. Through the leadership of Mark Papermaster, AMD has finally managed to live up to a marketing promise for its products. At its 2015 Investor Day, Papermaster promised to deliver a 40% improvement in “instructions per cycle” (IPC), and Summit Ridge has delivered.

candlestick chart: Lithium Americas Corp. (LACDF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Still, reading between the lines, it’s been clear which names he has liked over the months and years. Lithium Americas (OTCQX:LACDF) and SQM (NYSE:SQM) are prime examples. Consider that LAC shares have more than doubled from an early July low of C$0.78 (it closed at C$1.70 on Sept. 15th) when rumblings suggested that SQM might not move forward on the LAC/SQM Cauchari-Olaroz project. Joe was among the first to squash those rumors, setting up what turned out to be a highly profitable buying opportunity. SQM is up 120% in the past 12 months (by comparison, the Global X Lithium ETF (LIT) is up 54%, and the S&P 500 Index is up 16%).

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

candlestick chart: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

candlestick chart: Territorial Bancorp Inc.(TBNK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Territorial Bancorp (NASDAQ: TBNK) shares touched a new 52-week low of $21.31. Territorial Bancorp shares have dropped 9.43% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.

candlestick chart: Juniper Pharmaceuticals, Inc.(JNP)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap women’s health therapeutic stock Juniper Pharmaceuticals (NASDAQ: JNP):

  • [By Jim Robertson]

    On Monday, our Under the Radar Moversnewsletter suggested shorting women’s health stock Juniper Pharmaceuticals (NASDAQ: JNP):

    Juniper Pharmaceuticals shares have yet to break under a key support level at $5.00. But, waiting until that happens may be too late. After some continued testing of that floor, if-and-when the support should break, the ensuing selloff could materialize in a hurry. If you’re not it at the time it happens, you may not be able to get in at a decent price.

candlestick chart: J.M. Smucker Company (The)(SJM)

Advisors’ Opinion:

  • [By Teresa Rivas]

    J.M. Smucker(SJM) is falling Monday, after Morgan Stanley’sMatthew Grainger and his team cut their rating on the stock, citing pricing pressures from Wal-Mart (WMT) and growing competition from private-labels.

    Getty Images

    Grainger slash Smucker to Underweight from Equal Weight, and shaved $6 off his price target, to $126. He also cites what he calls “sustained” challenges in both its coffee and pet food business, as well as“below-average strategic optionality.”

    At the same time, he also upgraded Pinnacle Foods (PF) to Overweight from Equal Weight, and raised his price target to $63 from $58, on its double-digit earnings growth and what he sees as superior execution.

    Nonetheless, he sees many of the packaged food companies in his coverage, from Smucker to Pinnacle, as subject to pressure from Wal-Mart and off-brand rivals. From the note:

    Walmart comprises ~22% of sales across our coverage, a figure that has increased in recent years even as the retailers total grocery sales have grown at an even faster 4% CAGR. With Food margins expected to expand meaningfully, we believe this only enhances Walmart’s negotiating leverage going forward. SJM, Dean Foods (DF), and General Mills (GIS) are most at risk in the current environment, in our view.

    Recent scanner data points to a positive inflection in private label trends (share up ~30 bps L12W) across a range of center-store categories, a dynamic we believe could intensify in an increasingly competitive retail grocery landscape. Our analysis of recent trends points to the most meaningful underperformance vs. private label at GIS, SJM, ConAgra (CAG), and Campbell Soup (CPB), while only PF has outperformed in recent weeks.

    Smucker is down 1.1% to $127.95 this morning, while Pinnacle is up 0.8% to %48.47.

  • [By Douglas A. McIntyre]

    The Pillsbury Doughboy is the mascot of the Pillsbury Company, which is owned by General Mills (NYSE: GIS) and J.M. Smucker (NYSE: SJM). The Doughboy was created by Pillsburys advertising agency almost 50 years ago. Pikachu are characters owned by The Pokemon Company International and appear in card games, video games, TV shows, movies and comic books. Founded in 1998, the Japanese company has achieved total games sales of almost 280 million. SpongeBob SquarePants was created for Nickelodeon, which is owned by Viacom (NASDAQ: VIA). The show premiered in 1999 and has spawned movies, video games and theme park rides. Ronald McDonald is a c

candlestick chart: SVB Financial Group(SIVB)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, financial shares slipped by 0.55 percent. Meanwhile, top losers in the sector included Greenhill & Co., Inc. (NYSE: GHL), down 11 percent, and SVB Financial Group (NASDAQ: SIVB), down 8 percent.

  • [By Jon C. Ogg]

    SVB Financial Group (NASDAQ: SIVB) has a Buy rating at the firm, and this top pick among the bank stocks has a price objective of $190 versus a current $170.38 close. The parent of Silicon Valley Bank has a consensus analyst price target of $176.19, and its 52-week range is $77.87 to $176.77.

Top 10 Medical Stocks For 2018

Despite staggering increases in drug prices, Americans still aren’t living as long as those in other countries. And the worst part is they’re paying more, too…

One out of every four Americans reported that the cost of healthcare is their primary concern right now, according to a January 2017 Monmouth University poll. In fact, anxiety about paying medical bills now outpaces job and unemployment concerns, as well as worries about paying everyday household bills.

And it’s no wonder: In August, prices for medicine, doctor’s appointments, and health insurance rose at rates not seen since 1984.

Drug costs, in particular, are growing by double and triple digits each year. Back in October 2016, The Fiscal Times reported that specialty drug prices grew 18.9% and are projected to increase another 18.7% this year. Additionally, it reported that generic drug prices are expected to increase another 11% this year after already going up 11.3% in 2016.

Top 10 Medical Stocks For 2018: Netlist, Inc.(NLST)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Elite Opportunity Pronewsletter suggested small cap data/memory solutions stocksNetlist, Inc (NASDAQ: NLST) as a long/bullish position for our short term portfolio:

Top 10 Medical Stocks For 2018: 2U, Inc.(TWOU)

Advisors’ Opinion:

  • [By David Kretzmann]

    Since its IPO in March 2014, 2U (NASDAQ:TWOU) stock is up over 160% as the company forges partnerships with famous schools, including Georgetown, Yale, Berkeley, and New York University.

Top 10 Medical Stocks For 2018: V.F. Corporation(VFC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Ben Levisohn]

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

  • [By Jeremy Bowman]

    The North Face, in particular, seems like a cautionary tale. The outdoor gear and apparel maker had its IPO in 1996. By 1999 sales were falling and the company put up a $100 million loss. In 2000,VF Corporation(NYSE:VFC) acquired it for just $25.4 million, despite $238 million in sales and a once-popular brand. Today, under the guidance of VF Corp, The North Face now has more than $2 billion in annual sales.

Top 10 Medical Stocks For 2018: Siebert Financial Corp.(SIEB)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggested shorting small cap discount brokerageSiebert Financial Corp (NASDAQ: SIEB):

    Siebert Financial has been on our watchlist for a while, overbought and toying with the idea of a pullback. We’re finally starting to see evidence that the weight of the gain is taking a toll. We’ve seen a string of lower highs following the last bullish gasp from the 9th. We’re going to assume that was the pivot point. (It has been so far, anyway.)

  • [By Cameron Saucier]

    Siebert (Nasdaq: SIEB) is a holding company that has a retail discount brokerage business through its subsidiary, Muriel Siebert & Co. SIEB rose 60% last month after it announced a purchasing agreement with Kennedy Cabot Acquisition. Under the agreement, Kennedy Cabot will purchase shares of SIEB. SIEB is currently trading at $3.37 per share and is up 157% YOY.

  • [By Lisa Levin]

    Siebert Financial Corp. (NASDAQ: SIEB) shares shot up 61 percent to $8.30 following news it will offer deeply discounted online trading of U.S. equities next year.

Top 10 Medical Stocks For 2018: Benitec Biopharma Limited(BNTC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benitec Biopharma Ltd (ADR) (NASDAQ: BNTC) shares shot up 44 percent to $4.41. Benitec Biopharma disclosed that the key pre-clinical data on oculopharyngeal muscular dystrophy has been published in Nature Communications.

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

Top 10 Medical Stocks For 2018: Zynga Inc.(ZNGA)

Advisors’ Opinion:

  • [By Andrew Tonner]

    IPOs like Snap are a rare breed. In looking for companies comparable to it, I looked for listings that sported a post-IPO valuation above $5 billion, went pubic after 2010, and employ a consumer-facing business model. This resulted in an admittedly small sample of highly hyped tech IPOs including Facebook (NASDAQ:FB), Twitter (NYSE:TWTR), Groupon (NASDAQ:GRPN), and Zynga (NASDAQ:ZNGA). For transparency’s sake, I opted to not include Chinese e-commerce giant Alibaba in this list because its geographic focus and scale made it fundamentally different than the above tech IPOs, although including it wouldn’t have changed the outcome of this analysis.

  • [By Paul Ausick]

    According to the Financial Times, a total of 13 companies, including Zynga Inc. (NASDAQ: ZNGA) and Sears Holdings Corp. (NASDAQ: SHLD) saw shares rise to $123. For Zynga, that represented a 3,000% boost; for Sears, a 1,000% surge. Four companies, including Amazon and Alphabet Inc. (NASDAQ: GOOGL) fell more than 85% as a result of the glitch.

  • [By Shanthi Rexaline]

    Most tech companies opt to have the dual class structure with the primary motive of retaining voting control. Facebook Inc (NASDAQ: FB), Zynga Inc (NASDAQ: ZNGA), Groupon Inc (NASDAQ: GRPN) and Box Inc (NYSE: BOX) are a few companies who went the dual class stock structure way.

  • [By Peter Graham]

    A long term performance chart shows shares of Glu Mobile and peer Zynga Inc (NASDAQ: ZNGA)all over the place for investors and savvy traders who could have profitably traded theirshares:

  • [By WWW.THESTREET.COM]

    What could have gone wrong? Cramer said investors only need to remember the IPOs of Facebook (FB) , Twitter (TWTR) , Groupon (GRPN) and Zynga (ZNGA) . All of these IPOs made the markets look fragile and, yes, rigged. But today, the market avoided four major pitfalls.

  • [By David Zeiler]

    Institutional Venture Partners was the VC firm that led the round. IVP focuses on tech startups, having backed such names as Snap Inc. (NYSE: SNAP), Twitter Inc. (NYSE: TWTR), Zynga Inc. (Nasdaq: ZNGA), and Dropbox Inc.

Top 10 Medical Stocks For 2018: Virtu Financial, Inc.(VIRT)

Advisors’ Opinion:

  • [By Lee Jackson]

    Virtu Financial Inc. (NASDAQ: VIRT) had a large buyer at the desk last week. TJMT Holdings, an investment vehicle for the founder and Executive Chairman Vincent Viola, bought a 50,000 share blockat $15.88 apiece. The total price for the trade was $794,345. The company provides market making and liquidity services to the financial markets worldwide. Shares closed last Friday at $15.95, in a 52 week range of$12.35 to $23.97, and the consensus price target is $16.31.

Top 10 Medical Stocks For 2018: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

Top 10 Medical Stocks For 2018: Coca-Cola Enterprises, Inc.(CCE)

Advisors’ Opinion:

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

Top 10 Medical Stocks For 2018: Washington Federal, Inc.(WAFD)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
    Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

stock report

Shutterstock

If you are shopping for a mortgage, you have probably seen all sorts of offers and advertisements aimed at first-time home buyers and wondered if these are really as good as they sound. In some cases, “first-time” programs are little more than attention getting marketing messages from lenders, while in others they are actual assistance programs for people who may otherwise face challenges with qualifying for a home mortgage or finding a home loan at an affordable interest rate. With this in mind, it is important to understand the difference between mortgage lender marketing programs, actual loan programs, and financial assistance programs.

You can be a first-time home buyer more than once

First of all, even if you have previously owned a home, you (or your spouse) may still qualify as a first-time home buyer. According to the U.S. Department of Housing and Urban Development, first-time home buyer status is not limited to people who have never owned a home before (although that criteria obviously applies). For lending purposes, a first-time home buyer includes anyone who fits one or more of these conditions:

stock report: RenaissanceRe Holdings Ltd.(RNR)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    RenaissanceRe Holdings (RNR) is a global provider of reinsurance, as well as various types of insurance and related services. The company was founded in 1993 and is headquartered in Bermuda, notes Jack Adamo, editor of Insiders Plus.

stock report: Signet Jewelers Limited(SIG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was Signet Jewelers Limited (NYSE: SIG), which rose roughly 9% to $52.52. The stocks 52-week range is $46.09 to $101.46. Volume was nearly 5 million on the day compared to the average of 1.8 million.

  • [By Ben Levisohn]

    Signet Jewelers (SIG) soared to the top of the S&P 500 today after reporting better-than-expected earnings and offering a staunch defense of the company’s culture.

    Getty Images

    Signet Jewelersgained 8.7% to $70.02 today, while the S&P 500 ticked up 0.1% to 2,364.87.

    CFRA’s Efraim Levy still sees “risks” despite Signet’s defense of itself today:

    We lower our 12-month target by $4 to $81, or 11X our FY 18 (Jan.) EPS of $7.35 (reduced $0.30). We apply a P/E below SIG’s 10-year forward average of 13.4X, to reflect challenges of negative same-store sales, offset by our favorable longer-term view of SIG’s market position. SIG today addressed recent headlines, but we still see risks, despite implied upside potential to our target. Posts adjusted Jan-Q EPS of $4.03 vs. $3.63, in line with Capital IQ consensus and January guidance. Same-store sales fell an in-line 4.5%, dragged down by the Sterling Jewelers division.

    Signet Jewelers’ market capitalization rose to $4.9 billion today from $4.5 billion yesterday.

  • [By Peter Graham]

    A long term performance chart shows shares of Tiffany & Co heading back towards late 2014 highs while mid capSignet Jewelers Ltd (NYSE: SIG) peaked in late 2015 andhas continued to fall off since then:

stock report: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By Chris Lange]

    Salesforce.com Inc. (NYSE: CRM) fiscal third-quarter results also are scheduled for Tuesday. The consensus forecast is $0.37 in EPS on $2.65 billion in revenue. Shares were last seen at $107.58. The consensus price target is $115.20. The 52-week range is $66.43 to $107.85.

  • [By Sreekanth Anasa]

    According to Equities.com analyst Michael Markowski, Microsoft could be the first digital companyhit a $1 trillion market capitalization. As of Thursday, Microsoft had the third largest market cap of $486.83B, behind Apple Inc ($619.79B) and Alphabet Inc ($543.04B).Microsoft’s $26 billion acquisition of LinkedIn is the big ticket according toanalyst Michael Markowski.The LinkedIn acquisition expands its PE and positions Microsoft to capitalize from emerging online crowdsourced funding.Michael Markowski states”It has a monopoly on the business social media niche or community.” It is well positioned to take advantage of tons of data of 467M LinkedIn users.Microsoft also plans to use LinkedIns social graph to bolster its customer relationship management tool to compete with industry-leadersalesforce (NYSE:CRM).

  • [By WWW.MONEYSHOW.COM]

    Cloud-software leader Salesforce (CRM) – my Top Pick for 2017 among large cap technology stocks — remains well positioned to reap the benefits of the transition away from on-premises solutions.

  • [By WWW.THESTREET.COM]

    “There are two things that mess up your relationships, it’s anger and fear,” explains Robbins. Robbins points to Salesforce (CRM) CEO Marc Benioff as being a total giver, which has set him up for success in business.

stock report: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Biotech stocks are having a great day today–iShares Nasdaq Biotechnology ETF (IBB) has climbed 2.5% to $276.92–leading some to suggest that 2017 could be better for investors than 2016 was. Not Baird’s Brian Skorney and Michael Ulz, who “don’t think 2017 will be worse than 2016″ but “aren’t quite sure it will be much better.” They explain why:

    Agence France-Presse/Getty Images

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

    A steadily building pharma cash war chest is a big offsetting tailwind. As Princess Leia would say, “Help me M&A, you’re my only hope.”

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

  • [By Craig Jones]

    Guy Adami believes that iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) is a Buy. He explained that it held well in a tough trading session for the rest of the market.

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) and the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) were each approaching important support levels back in mid-November.

stock report: Match Group, Inc.(MTCH)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    In its first full year as a publicly traded company, online dating conglomerateMatch Group (NASDAQ:MTCH) surged past expectations, climbing 26%.

    A number of factors led to its standout performance, including blockbuster growth from Tinder, strong operating leverage, and consistently beaten earnings estimates. Let’s take a closer look at how things played out in 2016.

  • [By Peter Graham]

    Small cap dating site stock Match Group Inc (NASDAQ: MTCH), which was spun off from media and Internet stock IAC/InterActiveCorp (NASDAQ: IAC) and is a peer or remaining dating stock Spark Networks Inc (NYSEMKT: LOV), is the eight most shorted stock on theNASDAQ with short interest of 43.96% according to Highshortnterest.com.

stock report: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

Best Warren Buffett Stocks To Own Right Now

I won’t keep you in suspense — Warren Buffett-led Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) owns 400,000,000 shares of Coca-Cola (NYSE:KO), worth a total of $16.7 billion as of this writing. This translates to a 9.4% stake in the beverage giant, and makes Coca-Cola Buffett’s third-largest stock investment.

The investment has served Buffett and Berkshire’s shareholders well. Of the Coca-Cola stake’s market value, more than $15.4 billion represents profit. The $560 million in dividends it will receive this year from Coca-Cola represents nearly half of what Buffett paid for the shares in the first place. Here’s why Buffett likes Coca-Cola so much, and whether you should consider joining him in the investment.

Image Source: The Motley Fool.

Why does Buffett like Coca-Cola so much?

Coca-Cola is a longtime favorite stock of the Oracle of Omaha. Not only is Coca-Cola one of only two major stock positions Berkshire has held for more than 25 years (the other is Wells Fargo), but it’s consistently been among Berkshire’s top holdings. In fact, 25 years ago, Coca-Cola was the largest stock holding in Berkshire’s portfolio.

Best Warren Buffett Stocks To Own Right Now: Super Micro Computer, Inc.(SMCI)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, small cap Super Micro Computer (NASDAQ: SMCI) fell 7.52% after receivingnotification letter from Nasdaq stating that the Company is not in compliance with Nasdaq listing rule 5250(c)(1), which requires timely filing of reports with the SEC. Super Micro Computer isa global leader in high-performance, high-efficiency server technology and innovation, is a premier provider of end-to-end green computing solutions for Data Center, Cloud Computing, Enterprise IT, Hadoop/Big Data, HPC and Embedded Systems worldwide. Supermicro’s advanced Server Building Block Solutions庐 offer a vast array of components for building energy-efficient, application-optimized, computing solutions. Architecture innovations include Twin, TwinPro, FatTwin, Ultra Series, MicroCloud, MicroBlade, SuperBlade庐, Simply Double, Double-sided Storage庐, Battery Backup Power (BBP庐) modules and WIO/UIO. Products include servers, blades, GPU systems, workstations, motherboards, chassis, power supplies, storage, networking, server management software and SuperRack庐 cabinets/accessories delivering unrivaled performance and value.

Best Warren Buffett Stocks To Own Right Now: NTN Buzztime, Inc.(NTN)

Advisors’ Opinion:

  • [By Lisa Levin]

    NTN Buzztime Inc (NYSE: NTN) shares were also up, gaining 26 percent to $7.22. NTN Buzztime reported a Q4 loss of $0.22 per share on revenue of $5.98 million.

Best Warren Buffett Stocks To Own Right Now: NiSource, Inc(NI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, utilities shares fell by 2.01 percent. Meanwhile, top losers in the sector included Unitil Corporation (NYSE: UTL), down 9 percent, and NiSource Inc. (NYSE: NI), down 5 percent.

Best Warren Buffett Stocks To Own Right Now: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

Best Warren Buffett Stocks To Own Right Now: PIMCO 25+ Year Zero Coupon US Trs ETF (ZROZ)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Investors with a taste more rate-sensitive bond ETF may want to consider the PIMCO 25 Yr Zro Cupn US Ty Inx Fd ETF (NYSE: ZROZ) and the Vanguard Extended Duration ETF (NYSE: EDV).

free online stock trading

Several days ago Fitbit (FIT) and Dexcom (DXCM) announced they are partnering to develop CGM (continuous glucose monitoring) solutions for people living with diabetes. The first product will incorporate DXCM’s CGM data and bridge it with FIT’s new Ionic watch. Users of Android and iOS devices would be able to see “activity and glucose levels, right on their wrist.”

So what’s the big deal?

Th truth is that it isn’t such a big deal for DXCM. The company already sells and markets a similar product for both Android and iOS devices.

However, please note that the Ionic will have four days of battery life, which could be considered mission critical in such medical applications. Apple’s (AAPL) new iWatch 3 on the other hand clams to have up to 18 hours of battery life.

Also, the Ionic smartwatch has a built-in GPS tracker, an optical heart rate sensor, an accelerometer and a blood oxygen sensor. So perhaps DXCM and FIT might have more plans for medical Apps in the future. The AAPL iWatch does not have all those amenities, and to get the GPS tracker you have to fork out about $30 more.

free online stock trading: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

free online stock trading: Air Industries Group(AIRI)

Advisors’ Opinion:

  • [By Dividends4Life]

    Air Industries Group Inc. (AIRI), an aerospace and defense company, designs and manufactures structural parts and assemblies that focus on flight safety. Sept. 17, the company increased its quarterly dividend 100% to $0.125 per share. The dividend is is payable Oct. 15, 2013 to shareholders of record as of the close of business on Sept. 30, 2013. The yield based on the new payout is 6.9%.

free online stock trading: US Foods Holding Corp. (USFD)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Guggenheim’sJohn Heinbockel and team argue that a “purging of space is necessary” in retail, and recommend hiding in “industry leaders who canprofitably gain share and are not especially expensive,” like Michaels (MIK), Tractor Supply (TSCO), Restoration Hardware (RH), Kroger (KR),and US Foods Holding (USFD). They explain:

  • [By Jayson Derrick]

    But Amazon’s ultimate end-goal would likely be turning stores into “centralized distribution centers for groceries” but “we err on the futuristic side given Bezos thinks big.”

    Company Commentary
    Kroger Co (NYSE: KR) may be best positioned to counter Amazon’s threat given its own data analytics capabilities. SYSCO Corporation (NYSE: SYY) and US Foods Holding Corp (NYSE: USFD) are likely safe as Amazon won’t move into the foodservice distribution space which is very different from serving individual customers.

    Related Links:

free online stock trading: Tel-Instrument Electronics Corp.(TIK)

Advisors’ Opinion:

  • [By Monica Gerson]

     

    General Mills, Inc. (NYSE: GIS) is expected to report its quarterly earnings at $0.60 per share on revenue of $3.86 billion.
    Pier 1 Imports Inc (NYSE: PIR) is projected to post a quarterly loss at $0.05 per share on revenue of $420.05 million.
    Acuity Brands, Inc. (NYSE: AYI) is estimated to report its quarterly earnings at $2.03 per share on revenue of $847.79 million.
    Monsanto Company (NYSE: MON) is projected to report its quarterly earnings at $2.40 per share on revenue of $4.49 billion.
    Worthington Industries, Inc. (NYSE: WOR) is expected to report its quarterly earnings at $0.64 per share on revenue of $692.48 million.
    Progress Software Corporation (NASDAQ: PRGS) is projected to post its quarterly earnings at $0.29 per share on revenue of $94.64 million.
    UniFirst Corp (NYSE: UNF) is estimated to report its quarterly earnings at $1.34 per share on revenue of $366.28 million.
    Exfo Inc (NASDAQ: EXFO) is expected to post its quarterly earnings at $0.06 per share on revenue of $60.87 million.
    OMNOVA Solutions Inc. (NYSE: OMN) is projected to report its quarterly earnings at $0.14 per share on revenue of $205.40 million.
    8Point3 Energy Partners LP (NASDAQ: CAFD) is estimated to post a quarterly loss at $0.01 per share on revenue of $11.60 million.
    Park Electrochemical Corp. (NYSE: PKE) is expected to report its quarterly earnings at $0.22 per share on revenue of $35.30 million.
    Xplore Technologies Corp. (NASDAQ: XPLR) is projected to post its quarterly earnings at $0.01 per share on revenue of $24.00 million.
    Investors Real Estate Trust (NYSE: IRET) is expected to post its quarterly earnings at $0.14 per share on revenue of $56.87 million.
    Tel-Instrument Electronics Corp. (NYSE: TIK) is estimated to post earnings for the latest quarter.
    Aethlon Medical, Inc. (NASDAQ: AEMD) is expected to post a quarterly loss at $0.20 per share.
    Ossen Innovation Co Ltd (ADR) (NASDAQ: OSN) is projected to post ea

free online stock trading: Carter's, Inc.(CRI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

Hot Heal Care Stocks To Own Right Now

Benefitfocus

INTRODUCTION:

Benefitfocus (NASDAQ: BNFT) is a benefits management company that boasts, “A powerful data-driven platform to shop, enroll, manage and exchange benefits all in one place”. The South Carolina firm separates its solutions into those aimed at employers and those aimed at insurance companies. The stock price has fallen from a peak of $74/share in 2014 to trade at $30.90/share as of the 1/17/2017 market close. Despite this freefall, the company has made real progress towards its stated goals and there is cause for optimism that share price will begin to appreciate.

Financial Metric History

The Benefitfocus business has grown significantly over the past three calendar years. The rapid employer shift of benefits management to the cloud has empowered significant improvement in the most important financial metrics.

2013

Hot Heal Care Stocks To Own Right Now: South Jersey Industries Inc.(SJI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, utilities shares fell 0.73 percent. Meanwhile, top losers in the sector included Korea Electric Power Corporation (ADR) (NYSE: KEP), down 2 percent, and South Jersey Industries Inc (NYSE: SJI) down 2 percent.

  • [By Lisa Levin]

    In trading on Monday, utilities shares fell by 1.08 percent. Meanwhile, top losers in the sector included South Jersey Industries Inc (NYSE: SJI), down 4 percent, and MDU Resources Group Inc (NYSE: MDU), down 4 percent.

Hot Heal Care Stocks To Own Right Now: Eros International PLC(EROS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap Bollywood stock Eros International plc (NYSE: EROS) is the15th most shorted stock on the Nasdaq with short interest of 39.19% according to Highshortinterest.complus the Company has just reported earnings. Eros International is a leading global company in the Indian film entertainment industry that acquires, co-produces and distributes Indian films across all available formats such as cinema, television and digital new media. Eros International Plc was the first Indian media company to list on the New York Stock Exchange and is one of the oldest companies in the Indian film industry to focus on international markets as the Company has experience of over three decades in establishing a global platform for Indian cinema. The Company has a competitive advantage through its extensive and growing movie library comprising of over 3,000 films, which include Hindi, Tamil, and other regional language films for home entertainment distribution. Eros International has built a dynamic business model by combining the release of new films every year with the exploitation of its film library. The company also owns the rapidly growing OTT platform Eros Now.

Hot Heal Care Stocks To Own Right Now: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

Hot Heal Care Stocks To Own Right Now: Liberty Interactive Corporation(QVCA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    QVC (QVCA) was upgraded to buy from neutral at Bank of America/Merrill Lynch. $25 price target. The company can turn its sales around and deserves a higher multiple, analysts said. 

Hot Heal Care Stocks To Own Right Now: Alder BioPharmaceuticals, Inc.(ALDR)

Advisors’ Opinion:

  • [By Paul Ausick]

    Alder Biopharmaceuticals Inc. (NASDAQ: ALDR) posted a new 52-week low of $13.50on Tuesday, down nearly 28% compared with Monday’s closing price of $18.70. The stock’s 52-week high is $36.48. Volume totaled more than 12 million shares, about 12 times the daily average of around 720,000. The company reported that its migraine treatment reported a positive result, but investors were not impressed.

hot stocks for today

Loading the player…
What is ‘Net Present Value – NPV’

Net Present Value (NPV) is the difference between the present value of cash inflows and the present value of cash outflows. NPV is used in capital budgeting to analyze the profitability of a projected investment or project.

The following is the formula for calculating NPV:

where

Ct= net cash inflow during the period t

Co= total initial investment costs

r = discount rate, and

t = number of time periods

A positive net present value indicates that the projected earnings generated by a project or investment (in present dollars) exceeds the anticipated costs (also in present dollars). Generally, an investment with a positive NPV will be a profitable one and one with a negative NPV will result in a net loss. This concept is the basis for the Net Present Value Rule, which dictates that the only investments that should be made are those with positive NPV values.

hot stocks for today: AFC Enterprises Inc.(AFCE)

Advisors’ Opinion:

  • [By AnnaLisa Kraft]

    AFC Enterprises (NASDAQ: AFCE  ) , which owns the Popeye’s Louisiana Kitchen quick- serve chain, once an undiscovered gem, has now soared 66% over the last year.

hot stocks for today: Discover Financial Services(DFS)

Advisors’ Opinion:

  • [By JACK HOUGH]

    Like CVS, Discover has trounced the broad market over the long term but sold off recently. It’s down more than 15% this year. Costs rose early in the year in part due to one-time expenses related to anti-money-laundering efforts and other regulatory concerns. Analysts predict an offsetting decline in expenses next year. Don’t confuse Discover with a company that’s primarily in the business of running a credit-card network, like Visa (V) and MasterCard (MA). It’s basically a credit-card lender, like Capital One Financial (COF), that runs its own network to gain a competitive advantage.

    By saving on network fees, Discover can offer attractive card rewards, including a popular cash-back program. Any card lender can offer cash back, of course, but being too aggressive risks hurting margins. Discover has grown its portfolio of credit-card loans much faster than big banks have in recent years. And it has done so with industry-leading returns on capital. Rising growth could be on the way. Early this year, Discover went on a marketing spree. Last quarter, it reported its best card growth since 2007. Historically, new-card growth and loan growth have been closely correlated. In a November note to investors, Morgan Stanley analyst Cheryl Pate predicted accelerating loan growth within six months. Meanwhile, defaults remain low. Shares sell for less than 10 times projected earnings for the next four quarters, down from 12 times at the end of last year. They could rise 20% on a combination of earnings growth and a valuation rebound. The dividend yield is 2%. 

  • [By Matthew Cochrane]

    While a new year has been ushered in, it is clear PayPal’s philosophy has not changed. Last week, PayPal entered into another major agreement, this time with credit card issuerDiscover Financial Services (NYSE:DFS).

  • [By Ben Levisohn]

    We get the bull case.American Express is a blue-chip Dow component with an iconic global brand. It generates >30% returns on tangible, but it is trading well below its historical multiple and has underperformed post the election. Costco is now in the rearview mirror, and the string of negative surprises that have weighed on the stock are now poised to abate and position the company to start surprising positively. With Capital One Financial (COF), Discover Financial Services (DFS), and Synchrony Financial (SYF) all trading near their historical peaks, some have concluded thatAmerican Express is headed back to its historical high above $90. While this thought process may sound logical, we believe it only works in a world where generalists are steering the ship, and view it as highly susceptible to unraveling when negative revisions hit. American Express is not the business it once was, it doesnt have the same earnings power, and, in our view, it doesnt deserve to trade near its historical valuation.

hot stocks for today: Telefonica Brasil S.A.(VIV)

Advisors’ Opinion:

  • [By Sofia Horta e Costa]

    Vivendi (VIV) rose 2.7 percent to 17.15 euros. Music, pay-TV, European cinema and Internet in Brazil will make up a new media group based in France after the split with phone unit SFR, according to a statement yesterday.

  • [By Lisa Levin]

    In trading on Wednesday, telecommunications services shares slipped by 0.08 percent. Meanwhile, top losers in the sector included Turkcell Iletisim Hizmetleri A.S. (ADR) (NYSE: TKC), down 2 percent, and Telefonica Brasil SA (ADR) (NYSE: VIV), down 2.5 percent.

hot stocks for today: Cerus Corporation(CERS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, healthcare shares gained by 0.99 percent. Meanwhile, top gainers in the sector included Cerus Corporation (NASDAQ: CERS), and Air Methods Corp (NASDAQ: AIRM).

  • [By Paul Ausick]

    Cerus Corp. (NASDAQ: CERS) dropped about 27% Tuesday to post a new 52-week low of $2.19 after closing at $3.00 on Monday. The stock’s 52-week high is $7.64. Volume was about 5 times the daily average of around 1.6 million shares. The company had no specific news.

hot stocks for today: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.